Target and organ-at-risk robustness of clinical adaptive intensity-modulated proton therapy for esophageal cancer
- Visser, S. (Speaker)
Activity: Talk and presentation › Academic presentation › Academic
Activity: Talk and presentation › Academic presentation › Academic